Company News
-
Lupin receives Health Canada approval for Propranolol Hydrochloride ER Capsules
Company | News | 0 Comment | 16 Sep, 2019
Pharma major Lupin Limited (Lupin) announced that it has received approval for its Propranolol Hydrochloride Extended-Release (ER) Capsules, 60 mg, 80 mg, 120 mg and 160 mg from Health Cana...Read more
-
Dr. Reddy's announces the launch of Fosaprepitant for Injection in US market
Company | News | 0 Comment | 12 Sep, 2019
Dr. Reddy’s Laboratories has announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® (fosaprepitant) for injection, approved by the USFDA...Read more
-
Sanofi India to sell Ankleshwar site to Zentiva
Company | News | 0 Comment | 11 Sep, 2019
The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and transfer of its manufacturing facility at Ankleshwar, Gujarat to Zentiva and...Read more
-
LifeSan Clinical Research receives zero 483 observations from USFDA inspections
Company | News | 0 Comment | 11 Sep, 2019
LifeSan Clinical Research, the clinical research division of Centaur Pharmaceuticals was audited by the USFDA and was concluded with zero 483 observations which signifies complian...Read more
-
Lupin receives USFDA approval for Fosaprepitant for Injection
Company | News | 0 Comment | 06 Sep, 2019
Lupin has announced that it has received approval for its Fosaprepitant for Injection, 150 mg Single-Dose Vial, from the United States Food and Drug Administration. Lupin’s Fosaprepi...Read more
-
Alkem Labs receives USFDA’s Form 483 with 2 observations
Company | News | 0 Comment | 06 Sep, 2019
Alkem Laboratories has announced that the US FDA had conducted an inspection at the Company's manufacturing facility located at Daman, India from 26th August, 2019 to 30th August, 2019. At...Read more
-
Cadila Pharma creates awareness on depression
Company | News | 0 Comment | 05 Sep, 2019
Cadila Pharmaceuticals under its Cure with Compassion program conducted a social media campaign recently for creating awareness regarding Depression, a disease identified by the...Read more
-
Lupin collaborates with Boehringer Ingelheim for novel oncology drug
Company | News | 0 Comment | 04 Sep, 2019
Boehringer Ingelheim and Lupin Limited have announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targeted the...Read more
-
USFDA issues CRL for Biocon's NDA for insulin glargine
Company | News | 0 Comment | 03 Sep, 2019
Biocon said that the US Food and Drug Administration (US FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for insulin glargine filed by partner Mylan.&nbs...Read more
-
Granules India to divest its stake in its JV located in India
Company | News | 0 Comment | 29 Aug, 2019
Granules India Ltd. has announced its intention to divest its entire equity shareholding in Granules OmniChem Private Limited (GOC) by selling its stake to its joint venture partner. GOC i...Read more
-
Company | News | 0 Comment | 29 Aug, 2019
Alstrut is a company based out of Chennai offering robotics and end of line automation solutions to discrete manufacturing industries across India. Solutions include automated/semi-automat...Read more
-
Lupin signs commercial agreement with Creso Pharma for cannaQIX
Company | News | 0 Comment | 27 Aug, 2019
Pharma major Lupin Limited has announced that its subsidiary in South Africa, ‘Pharma Dynamics’ has signed a Commercial Agreement with Creso Pharma for the hemp oil based cannaQ...Read more
-
Zydus initiates phase II trial for NAFLD drug
Company | News | 1 Comment | 22 Aug, 2019
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated a Phase 2 clinical trial for evaluating the effect of Saroglitazar Mg in the treatment of ...Read more
-
Dr. Reddy's launches Versavo in India
Company | News | 0 Comment | 19 Aug, 2019
Dr. Reddy’s Laboratories Ltd. has launched Versavo® (bevacizumab), a biosimilar of Roche’s Avastin® in India, indicated for the treatment of several types of cancers (me...Read more
-
Glenmark receives approval for combination drug for diabetes
Company | News | 0 Comment | 20 Aug, 2019
Glenmark Pharmaceuticals has received regulatory approval to market a combination of its novel, patent protected and globally-researched sodium glucose co-transporter-2 (SGLT2) inhibitor Re...Read more
-
Sun Pharma to develop more generic products in China
Company | News | 0 Comment | 19 Aug, 2019
Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to de...Read more
-
Roche announces first FDA approved tumour agnostic medicine
Company | News | 0 Comment | 16 Aug, 2019
Roche has announced that the US Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung...Read more
-
Abbott to showcase technologies overcoming health challenges
Company | News | 0 Comment | 14 Aug, 2019
Abbott builds on the success of its “Real Heroes campaign,” which was shortlisted for a Cannes Lion award, with new advertisements that demonstrate how our life-changing technol...Read more
